Has John Pittman received payments from drug or device companies?

Yes. Drug and device makers reported $38,544 in general payments to John Pittman across 648 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Pittman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Pittman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Pittman

Family Medicine · Oklahoma City, OKNPI 1588646988

Payments from drug & device makers

$38,544in general payments, 2019–2025

Across 648 payments — averaging $59.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bayer$19K
Lilly USA, LLC$4K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
Johnson & Johnson$2K
AstraZeneca$1K
Novo Nordisk$890
plus $9K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bayer	29	$18,600
Lilly USA, LLC	53	$4,321
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	26	$2,642
Johnson & Johnson	40	$2,155
AstraZeneca	51	$1,047
Novo Nordisk	33	$890
Otsuka America Pharmaceutical, Inc.	51	$830
Amgen	40	$768
Esperion Therapeutics, Inc.	14	$482
Daiichi Sankyo Inc.	25	$467
Sanofi-aventis U.S. LLC	12	$389
Boehringer Ingelheim	23	$388
Amarin Pharma, Inc.	17	$385
AbbVie(2 entities)	17	$340
Supernus Pharmaceuticals, Inc.	29	$313
Relievant Medsystems, Inc.	2	$261
Pfizer	23	$250
Abbott	2	$244
Takeda Pharmaceuticals U.S.A., Inc.	18	$240
Merck	20	$238
Astellas Pharma US Inc	14	$235
Novartis	5	$191
Ironshore Pharmaceuticals Inc.	6	$186
GSK	8	$178
Eisai Inc.	4	$166
Kowa Pharmaceuticals America, Inc.	4	$160
Biohaven Pharmaceuticals, Inc.	9	$149
Regeneron	1	$125
Therapeuticsmd, Inc.	2	$125
Corcept Therapeutics	1	$124
Tersera Therapeutics LLC	7	$123
Medtronic	2	$116
AMAG Pharmaceuticals, Inc.	1	$115
Stryker	1	$114
Incyte Corporation	1	$93
Antares Pharma, Inc.	6	$91
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$85
Boston Scientific	2	$85
SK Life Science, Inc.	4	$81
Clarus Therapeutics Inc.	5	$78
Sunovion Pharmaceuticals Inc.	4	$77
Regeneron Healthcare Solutions, Inc.	1	$77
Virtus Pharmaceuticals LLC	4	$58
Vertical Pharmaceuticals, LLC	2	$45
Tris Pharma Inc	3	$39
Flowonix Medical Incorporated	1	$39
Harmony Biosciences LLC	2	$38
Amneal Pharmaceuticals LLC	3	$38
Kaleo, Inc.	2	$31
Sage Therapeutics, LLC	2	$27
Dermira, Inc.	2	$26
Teva Pharmaceuticals USA, Inc.	2	$25
Endo USA, Inc.	1	$23
Biogen	1	$19
Bausch Health US, LLC	1	$17
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$17
IBSA Pharma Inc.	1	$16
Phadia US Inc.	1	$15
Sanofi Pasteur Inc.	1	$12
Aytu Biopharma, Inc.	1	$12

How this compares

$38,544 in reported general payments places this provider in the 95th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma →

Other family medicine in Oklahoma City

Carl GriffinOklahoma City$28.2M
Alexander FrankOklahoma City$3.1M
Charles LunnOklahoma City$1.4M
Hieu NguyenOklahoma City$238K
Melinda CailOklahoma City$122K
Jose Maria Borrego AcostaOklahoma City$106K
Brett CauthenOklahoma City$77K
Angelique BarretoOklahoma City$74K
Terrence TruongOklahoma City$32K
Jonathon KnoxOklahoma City$20K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →